STOCK SUBSCRIPTION AGREEMENTStock Subscription Agreement • April 5th, 2016 • Citius Pharmaceuticals, Inc. • Motor vehicle parts & accessories • New York
THIS STOCK SUBSCRIPTION AGREEMENT (the "Agreement"), dated as of March 30, 2016 is entered into by and between Citius Pharmaceuticals, Inc., a Nevada corporation (the "Corporation"), and Leonard Mazur, an individual with an address 32 Arden Road, Mountain Lakes, New Jersey 07046 (the "Subscriber").
VOTING AGREEMENTVoting Agreement • April 5th, 2016 • Citius Pharmaceuticals, Inc. • Motor vehicle parts & accessories • New York
THIS VOTING AGREEMENT (this "Agreement"), is made and entered into as of this 30th day of March, 2016, by and among Citius Pharmaceuticals, Inc., a Nevada corporation (the "Company"), Leonard Mazur, an individual with an address at 32 Arden Road, Mountain Lakes, New Jersey 07046 (the "Investor") and those certain stockholders of the Company listed on Schedule B (together with any subsequent stockholders, who become parties hereto as "Key Holders" pursuant to Section 4.2 below, the "Key Holders," and together collectively with the Investor, the "Stockholders").
AGREEMENT AND PLAN OF MERGER BY AND AMONG CITIUS PHARMACEUTICALS, INC., CITIUS LMB ACQUSITION CORP. AND LEONARD-MERON BIOSCIENCES, INC. Dated as of March 30, 2016 AGREEMENT OF PLAN AND MERGERAgreement and Plan of Merger • April 5th, 2016 • Citius Pharmaceuticals, Inc. • Motor vehicle parts & accessories • New York
This AGREEMENT AND PLAN OF MERGER, dated as of March 30, 2016 (this "Agreement"), is entered into by and among CITIUS PHARMACEUTICALS, INC., a Nevada corporation ("Citius"), CITIUS LMB ACQUISITION CORP., a Delaware corporation and a wholly owned subsidiary of Citius ("SubCo"), and LEONARD-MERON BIOSCIENCES, INC., a Delaware corporation ("LMB").
EMPLOYMENT AGREEMENTEmployment Agreement • April 5th, 2016 • Citius Pharmaceuticals, Inc. • Motor vehicle parts & accessories • New Jersey
This EMPLOYMENT AGREEMENT (the "Agreement"), is entered into effective as of March 1, 2016 (the "Effective Date"), by and between Citius Pharmaceuticals, Inc., a Nevada corporation with principal executive offices at 63 Great Road, Maynard Massachusetts 01754 (the "Company"), and Myron Holubiak, residing at 1544 Edly Cove Court, North Brunswick, New Jersey 08902 (the "Executive").
